or villains? Government admits multiple side-effects of COVID-19 jabs in RTI
The COVID-19 vaccines, which were administered to over a billion Indians over the course of more than two years, have “multiple side effects,” according to the government’s two top watchdogs.
The shocking information was provided in an RTI response to Pune businessman Prafful Sarda by the Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organization (CDSCO).
The vaccines of three Hyderabad-based companies—the government-run Bharat Biotech Ltd.’s “Covaxin,” Dr. Reddy’s Lab imported “Sputnik V,” Biological E. Ltd.’s “CorBEvax,” and later, Cadila Healthcare Ltd., Ahmedabad’s “ZyCov-D”—have been authorized by India but only for teenagers (12-17 age).
In response to a specific question from Sarda about the side effects of all these vaccinations, the PIOs of the ICMR, Dr. Leyanna Susan George, and CDSCO, Sushanta Sarkar, listed a variety of consequences resulting from all these vaccinations in their FAQs.
The majority of Covishield’s side effects are related to the jabbed janta injection site, including tenderness or pain, multiple red spots or bruises outside of the injection site, persistent vomiting without cause, severe or persistent abdominal pain or headaches with or without vomiting, shortness of breath, chest pains, pain in the limbs or swelling on pressing the calf/arms, pain in the limbs or swelling on pressing, weakness/paralysis of the limbs of any particular side
The side effects of Covovax include injection site pain/tenderness/induration, weakness, malaise, headaches, fever, soreness of muscles, joint pains, nausea or vomiting, chills, body ache or extreme pain in limbs, asthenia (weakness or lack of energy), injection site pruritus (itching, rash, red skin, hives), enlarged lymph nodes, back pains, and infrequently dizziness or drowsiness
Covaxin exhibits mild AEFI symptoms such as pain or swelling at the injection site, headaches, fatigue, fever, body aches, abdominal pain, nausea, vomiting, dizziness, giddiness, tremors, sweating, cold, and cough.
Chills, fever, arthralgia, myalgia, asthenia, headaches, general discomfort, pain or swelling at the injection site or hyperemia, nausea, dyspepsia, appetite loss, or occasionally enlarged regional lymph nodes are symptoms of Sputnik V.
In addition to injection site pain/erythema, swelling, rash, pruritis, or irritation, CorBEvax causes side effects like fever/pyrexia, headaches, fatigue, body pains, myalgia, nausea, or arthralgia, urticaria, chills, and lethargy.
“The ICMR-responses CDSCO’s are blatantly shocking. Even though the government has stated that vaccination is “totally voluntary,” why was the compulsion indirectly created by forbidding people from taking buses, trains, flights, interstate travel, dining out, going to hotels, restaurants, multiplexes, malls, etc? As a result, more and more terrified people were forced to inject themselves without understanding the consequences “Sarda spoke sternly.
Read also: Uganda Declares End of Deadly Ebola Outbreak
Now that vaccine-related deaths are being reported in India and around the world, he urged the government to release information on whether adequate publicity on all these potential side-effects was done through the media, by hospitals, and vaccination centers, and if the health ministry initiated any public safety campaigns for the gullible masses.
Sarda cited how India had given away millions of dollars worth of free vaccines to many developing nations, causing a scandal in 2021, and he questioned whether the people in those countries had been informed of all the possible side effects of the shots.
“All international organizations have established the standard that only vaccine candidates with efficacy rates of at least 50% to 60% will be taken into consideration. Within the brief window of two or three months of observation, the majority of vaccines have demonstrated an efficacy of 70% to 90%. The COVID-19 vaccine has been administered to more than 100 crore people, and the incidence of side effects is very low “The administration promised.
From August 2022, after the initial round of mostly free mass vaccinations was finished, the government has allowed the conditional market sales of Covishield and Covaxin, but Sputnik V and CorBEvax remain only for “restricted emergency use,” according to the RTI.